Filing metadata

Accession number
0001209191-21-057629
Form type
Form 4
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
Sep 24, 2021
Reporting period
Sep 22, 2021
Description
Insider transaction

Explore SEC Filings Hub